<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:content="http://purl.org/rss/1.0/modules/content/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://adc.bmj.com">
<title>Archives of Disease in Childhood Reviews</title>
<link>http://adc.bmj.com</link>
<description>Archives of Disease in Childhood RSS feed -- recent Reviews articles</description>
<prism:eIssn>1468-2044</prism:eIssn>
<prism:publicationName>Archives of Disease in Childhood</prism:publicationName>
<prism:issn>0003-9888</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://adc.bmj.com/cgi/content/short/98/1/60?rss=1" />
  <rdf:li rdf:resource="http://adc.bmj.com/cgi/content/short/98/1/66?rss=1" />
  <rdf:li rdf:resource="http://adc.bmj.com/cgi/content/short/98/1/72?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://hwmaint.adc.bmj.com/misc/home/ADC_95x60.gif" />
</channel>
<image rdf:about="http://hwmaint.adc.bmj.com/misc/home/ADC_95x60.gif">
<title>Archives of Disease in Childhood</title>
<url>http://hwmaint.adc.bmj.com/misc/home/ADC_95x60.gif</url>
<link>http://adc.bmj.com</link>
</image>
<item rdf:about="http://adc.bmj.com/cgi/content/short/98/1/60?rss=1">
<title><![CDATA[Unwarranted variation in health care for children and young people]]></title>
<link>http://adc.bmj.com/cgi/content/short/98/1/60?rss=1</link>
<description><![CDATA[
<p>The study of geographical variation in healthcare has moved on since J Allison Glover's seminal study in 1938, and its value in highlighting inequity in access, quality and outcomes is well-established. Study of variation in healthcare for children, however, has proven more difficult due to barriers with data and idiosyncrasies in how we measure outcomes for children and families. This paper is a narrative review of unwarranted variations in healthcare for children, and discusses the potential of variation analysis to help researchers and policy makers improve child health services.</p>
]]></description>
<dc:creator><![CDATA[Cheung, C. R. L. H., Gray, J. A. M.]]></dc:creator>
<dc:date>2012-12-19T00:29:52-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-302041</dc:identifier>
<dc:identifier>hwp:master-id:archdischild;archdischild-2012-302041</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Editor's choice]]></dc:subject>
<dc:title><![CDATA[Unwarranted variation in health care for children and young people]]></dc:title>
<prism:publicationDate>2013-01-01</prism:publicationDate>
<prism:section>Reviews</prism:section>
<prism:volume>98</prism:volume>
<prism:number>1</prism:number>
<prism:startingPage>60</prism:startingPage>
<prism:endingPage>65</prism:endingPage>
</item>
<item rdf:about="http://adc.bmj.com/cgi/content/short/98/1/66?rss=1">
<title><![CDATA[Investigation following resuscitated cardiac arrest]]></title>
<link>http://adc.bmj.com/cgi/content/short/98/1/66?rss=1</link>
<description><![CDATA[
<sec>
<p>Roughly two thirds of resuscitated cardiac arrests in children and youth are due to inherited heart diseases. The most commonly implicated are the cardiac ion channelopathies long QT syndrome, CPVT (catecholaminergic polymorphic ventricular tachycardia) and Brugada syndrome. Diagnosis is pivotal to further management of the child if he/she survives, and also to other family members who may be at risk. Thorough investigation of the cardiac arrest survivor is essential to either identify or exclude inherited heart disease. If standard cardiac investigation does not reveal a diagnosis, pharmacological provocation tests are needed to unmask electrocardiographic signs of disease, even if, due to severe brain injury, it is planned ultimately to allow a natural death. Examples are the ajmaline/flecainide challenge for Brugada syndrome and epinephrine for CPVT. A supportive, informative and sympathetic approach to the family is essential. An arrhythmia specialist and a cardiac genetic service should be involved early, with storage of DNA and cardiac/genetic investigation of the family. This review proposes a diagnostic algorithm-based approach to the investigation of this increasingly common clinical scenario.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Skinner, J. R.]]></dc:creator>
<dc:date>2012-12-19T00:29:52-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-301515</dc:identifier>
<dc:identifier>hwp:master-id:archdischild;archdischild-2011-301515</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Investigation following resuscitated cardiac arrest]]></dc:title>
<prism:publicationDate>2013-01-01</prism:publicationDate>
<prism:section>Reviews</prism:section>
<prism:volume>98</prism:volume>
<prism:number>1</prism:number>
<prism:startingPage>66</prism:startingPage>
<prism:endingPage>71</prism:endingPage>
</item>
<item rdf:about="http://adc.bmj.com/cgi/content/short/98/1/72?rss=1">
<title><![CDATA[Protracted bacterial bronchitis: reinventing an old disease]]></title>
<link>http://adc.bmj.com/cgi/content/short/98/1/72?rss=1</link>
<description><![CDATA[
<p>Chronic cough is common in the paediatric population, yet the true prevalence of this condition remains difficult to define. Protracted bacterial bronchitis (PBB) is a disease caused by the chronic infection of the conducting airways. In many children the condition appears to be secondary to impaired mucociliary clearance that creates a niche for bacteria to become established, probably in the form of biofilms. In others, immunodeficiencies, which may be subtle, appear to be a factor. PBB causes persistent coughing and disturbed sleep, and affects exercise tolerance, causing significant levels of morbidity. PBB has remained largely unrecognised and is often misdiagnosed as asthma.</p>
]]></description>
<dc:creator><![CDATA[Craven, V., Everard, M. L.]]></dc:creator>
<dc:date>2012-12-19T00:29:52-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2012-302760</dc:identifier>
<dc:identifier>hwp:master-id:archdischild;archdischild-2012-302760</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Protracted bacterial bronchitis: reinventing an old disease]]></dc:title>
<prism:publicationDate>2013-01-01</prism:publicationDate>
<prism:section>Reviews</prism:section>
<prism:volume>98</prism:volume>
<prism:number>1</prism:number>
<prism:startingPage>72</prism:startingPage>
<prism:endingPage>76</prism:endingPage>
</item>
</rdf:RDF>